IDO2 in Immunomodulation and Autoimmune Disease.

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Indoleamine 2,3-dioxygenase 2 (IDO2) is related to IDO1, involved in tryptophan metabolism and immune modulation, but its precise functions are unclear.
• Evolutionary genetics suggest IDO2 has a unique ancestral function distinct from IDO1.

Purpose of the Study:

• To elucidate the specific roles of IDO2 in normal physiology and pathophysiology.
• To investigate the differences in function and regulation between IDO2 and IDO1.

Main Methods:

• Gene deletion studies in mice (IDO2 knockout).
• Analysis of gene expression patterns and regulation (AhR pathway).
• Assessment of immune responses in mouse models (rheumatoid arthritis) and human populations.
• Biochemical and pharmacological characterization of IDO2 enzymology.

Main Results:

• IDO2 deletion in mice affects allergic/autoimmune responses and T regulatory cell generation, without impacting development or hematopoiesis.
• IDO2 is regulated by the aryl hydrocarbon receptor (AhR) and has a narrower expression pattern than IDO1.
• In a rheumatoid arthritis model, IDO2 deletion blunts autoantigen response but not neoantigen response.
• Human genetic variations in IDO2 correlate with brain cancer control and immune responses to IDO2, suggesting a role in immune tolerance.

Conclusions:

• IDO2 functions distinctly from IDO1, potentially acting as a set-point for tolerance to "altered-self" antigens.
• IDO2 is implicated in shaping immune tolerance in humans, influencing responses to cancer and autoimmunity.